Business Context and Reporting Period
Company: Village Farms International, Inc. (VFF)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2025
Business Overview: VFF operates in five segments: Canadian Cannabis (Pure Sunfarms, Rose LifeScience), U.S. Cannabis (Balanced Health), Netherlands Cannabis (Leli Holland), Produce (VFCLP), and Clean Energy. The company focuses on greenhouse cultivation of cannabis and produce, with a strategic shift toward international cannabis exports and a reduced footprint in the U.S. CBD market.
Key Financial Metrics
| Metric (in thousands USD) | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2025 |
|---|---|---|
| Total Revenue | $59,899 | $99,579 |
| Gross Profit | $22,342 | $36,522 |
| Gross Margin | 37.3% | 36.7% |
| Net Income (Attributable to Shareholders) | $26,497 | $19,794 |
| Adjusted EBITDA | $13,260 | $13,341 |
| Cash and Cash Equivalents | $59,988 | $59,988 (Balance Sheet) |
| Total Debt (Current + Long-Term) | $39,103 | $39,103 (Balance Sheet) |
| Working Capital | $85,753 | N/A |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $26.5 million for the quarter, a significant improvement from a net loss of $23.5 million in the same period in 2024. This reversal is primarily driven by a $19.1 million gain on the sale of discontinued operations and improved operating margins in the Canadian Cannabis segment.
- Discontinued Operations: On May 30, 2025, the company privatized certain assets of its Produce segment (Marfa II, Fort Davis greenhouses, and distribution centers) via a transaction with Vanguard Food LP. This resulted in a $19.985 million pre-tax gain on sale, classified as discontinued operations.
- Revenue Growth: Total revenue increased 12% year-over-year for the quarter ($59.9M vs. $53.6M). Growth was driven by a 690% increase in international cannabis export sales and the commencement of sales in the Netherlands (Leli Holland), partially offset by a decline in U.S. Cannabis sales due to regulatory restrictions.
- Impairments: Unlike the prior year, which included an $11.9 million goodwill and intangible impairment charge in the U.S. Cannabis segment, no impairments were recorded in the current period.
- Debt Refinancing: In April 2025, the company refinanced its Pure Sunfarms debt facilities, consolidating multiple loans into a new secured credit facility with a lower interest rate (approx. 5.25% vs. previous rates) and extended maturity dates.
Guidance, Outlook, and Risks
- Canadian Cannabis Outlook: Management expects to maintain a top-three market share position in Canada. International export sales are projected to remain strong, with the company aiming to be a leading importer of medical cannabis to Europe. A new investment to expand cultivation capacity at the Delta, BC campus was approved to meet demand.
- Netherlands Expansion: Leli Holland operations are ramping toward full capacity. Phase II facility construction in Groningen is on track for Q1 2026, expected to quintuple annualized production capacity.
- U.S. Cannabis Challenges: The segment faces headwinds from new CBD sales restrictions in eight states and competition from unregulated hemp-derived products. Sales are expected to remain under pressure.
- Produce Segment: Following the privatization, the Produce segment's results are now predominantly comprised of activities related to the Delta 1 and Delta 2 greenhouses, which supply Vanguard under a multi-year agreement.
- Risks: Key risks include regulatory changes in the cannabis industry (U.S. and Canada), foreign exchange exposure (CAD/USD), interest rate fluctuations on variable debt, and the ability to realize expected benefits from the Vanguard partnership.
Investor Verification Checklist
- Discontinued Operations Gain: Verify the final calculation of the $19.985 million gain on the Vanguard transaction, as it is subject to post-closing working capital adjustments.
- International Export Volumes: Confirm the sustainability of the 690% year-over-year growth in international cannabis exports and the specific contribution of the German and European markets.
- Debt Covenants: Review the specific financial covenants under the new Pure Sunfarms Secured Credit Facilities and the FCC Term Loan to ensure ongoing compliance.
- U.S. Regulatory Landscape: Monitor the impact of the July 1, 2024, CBD restrictions in eight states on the Balanced Health segment's future revenue trajectory.
- Capital Expenditures: Assess the funding source and timeline for the announced expansion of the Delta, BC cannabis production campus.